Question 1

A young female has a Pap test which reveals atypical squamous cells of undetermined significance. What will the next step be in managing this patient?&#10;A) Colposcopy with biopsy&#10;B) Endometrial sampling&#10;C) Reflex HPV DNA test&#10;D) Repeat cytology in 12 months

Accepted Answer

D

Question 2

What is true about genital human papillomavirus (HPV) infection in women?&#10;A) A single, isolated HPV infection will lead to cervical cancer.&#10;B) HPV subtypes causing genital warts indicate the likelihood of cancer.&#10;C) Most HPV lesions will resolve spontaneously without causing cancer.&#10;D) Most women with HPV infection will develop cervical cancer.

Accepted Answer

Most genital HPV infections do not cause any symptoms and resolve on their own without causing cancer. Only certain high-risk HPV types can lead to cancer, and even then, only a small percentage of women with these infections will develop cancer. Genital warts caused by low-risk HPV types do not indicate an increased risk of cancer. A single, isolated HPV infection is unlikely to cause cervical cancer, as it typically takes persistent infection with high-risk HPV types for many years to develop into cancer.

Question 3

What is the benefit of using a liquid-based medium when performing a Pap test?&#10;A) It allows genital human papillomavirus (HPV), gonorrhea, and chlamydia testing with the same specimen.&#10;B) It is a more accurate test than the slide method of Pap testing.&#10;C) It is not necessary to use endocervical cells to obtain results.&#10;D) It is predictive of the later development of cervical cancer.

Accepted Answer

Using a liquid-based medium allows for the collection of cells from the cervix and surrounding areas, which can be used for additional testing for genital human papillomavirus (HPV), gonorrhea, and chlamydia with the same specimen. This can improve the accuracy of the overall screening process and lead to earlier detection and treatment of these infections, which can reduce the risk of developing cervical cancer.

Deck 149: Cervical Cancer Screening Abnormalities